The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Integrating Methods for mAb Production
Distinct Advantages Result from Combining a Broad Array of Tools and Technologies
- Scientists working in the bioprocess arena have a lot on their plates lately, including choosing between single-use and stainless steel equipment, integrating processes and instruments, and improving resource and facility utilization. Tool companies are scrambling to do their part to help customers by introducing enabling products that seek to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.